Form 8-K Vanda Pharmaceuticals For: Dec 14 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vanda Pharmaceuticals Provides an Update to HETLIOZ® ANDA Litigation Appeal: Federal Circuit grants motion to temporarily enjoin generic launch WASHINGTON, Dec. 16, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provided an update on its appeal of…
Form 8-K Vanda Pharmaceuticals For: Dec 13 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Retail Investors Slamming The Bid Amid Tax-Loss Selling Capitulation Retail Investors Slamming The Bid Amid Tax-Loss Selling Capitulation …
Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Litigation WASHINGTON, Dec. 13, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today responded to the ruling in its HETLIOZ®…
Vanda Pharmaceuticals Shares Tumble After Loss in Hetlioz Patent Suit >VNDA Vanda Pharmaceuticals Shares Tumble After Loss in Hetlioz Patent Suit >VNDA...…
Vanda Pharmaceuticals plunges after loss in Hetlioz patent case Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: President and CEO verkauft Aktien von Vanda Pharmaceuticals im Wert von 512.082$ Polymeropoulos, Mihael Hristos - Vorstand - Tag der Transaktion: 2022-12-06...…
Insiderhandel: SVP, CFO & Treasurer verkauft Aktien von Vanda Pharmaceuticals im Wert von 50.827$ Moran, Kevin Patrick - Vorstand - Tag der Transaktion: 2022-12-06...…
Insiderhandel: President and CEO verkauft Aktien von Vanda Pharmaceuticals im Wert von 506.200$ Polymeropoulos, Mihael Hristos - Vorstand - Tag der Transaktion: 2022-12-05...…
Vanda says performance anxiety drug lowered stress in Phase 2 enrollees Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vanda Pharmaceuticals Announces Participation at November 2022 Investor Conferences WASHINGTON, Nov. 8, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in…
Vanda Pharmaceuticals (VNDA) Lags Q3 Earnings and Revenue Estimates Vanda (VNDA) delivered earnings and revenue surprises of -40% and 8%, respectively, for the quarter ended September 2022. Do the…
Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022 Conference Call and Webcast to Follow WASHINGTON, Oct. 26, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced…
Vanda granted FDA’s Orphan Drug Designation for cholera therapy Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VPO-227, a Novel Candidate for the Treatment of Cholera WASHINGTON, Oct. 21, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food and Drug Administration…
Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the Vanda Securities Litigation NEW YORK, Oct. 7, 2022 /PRNewswire/ -- UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK KENNETH GORDON, Individually and…
Pound rallies on 45p tax rate U-turn; recession fears mount – business live Rolling coverage of the latest economic and financial newsPolitics Live: Truss expected to abandon plan to abolish 45% top rate…